Ion Beam Applications is a Belgium-based company focused on developing and marketing technologies and pharmaceutical products for the healthcare sector, specifically in cancer diagnosis and treatment. The company operates primarily through two segments: pharmaceuticals and equipment. The pharmaceuticals segment includes radiopharmaceuticals, while the equipment segment encompasses proton therapy systems, particle accelerators, and dosimetry solutions. IBA's proton therapy and accelerator business is a significant contributor to its revenues, providing precision cancer treatment using proton beams and cyclotrons for radioisotope production. Additionally, the dosimetry segment offers measurement and quality assurance tools for radiotherapy and medical imaging. IBA serves various markets, including Belgium, the United States, and other regions, while also engaging in sterilization and ionization applications.
PanTera focuses on the large-scale production of actinium-225, a promising radioisotope for targeted cancer therapies. The company aims to improve accessibility to personalized nuclear medicine treatments while ensuring sustainability through the recycling of materials in their production process.
Radcal
Acquisition in 2024
Radcal specializes in developing and manufacturing diagnostic X-ray imaging solutions for the medical and healthcare sectors. The company provides a diverse array of products, including ion chambers, solid-state sensors, current probes, and radiography accessories. These devices are designed to assist healthcare professionals in ensuring minimal radiation exposure and achieving accurate diagnoses during medical procedures. By focusing on advanced instrumentation and related products, Radcal aims to enhance the safety and effectiveness of diagnostic imaging practices.
Hil Applied Medical
Corporate Round in 2016
HIL Applied Medical is developing a new class of ultra-compact, high-performance accelerators for proton therapy. HIL applies a patented approach to particle acceleration and beam delivery, combining nano-technology with ultra-high-intensity lasers and ultra-fast magnets. These technological breakthroughs enable meaningful reduction in the size, complexity and cost of proton therapy systems, without compromising clinical utility. Thus HIL aims to enable, for the first time, a single-room add-on proton therapy solution that is truly cost-effective. HIL Applied Medical is a privately-held company, backed by VCs and global strategic partners. It is headquartered in the High-Tech Park, Givat Ram, Jerusalem, Israel; and have a wholly-owned subsidiary in Reno, Nevada (United States).
New Mexico Positron
Acquisition in 2005
New Mexico Positron manufactures and distributes Positron Emission Tomography (PET) tracers.
RadioMed Corporation
Acquisition in 2003
RadioMed Corporation, a developer of medical devices incorporating radioisotopes for inhibition of cellular proliferation.
Sotera Health
Acquisition in 1999
Sterigenics has delivered safer, smarter and more productive contract sterilization solutions to the medical device and pharmaceutical industries, using Ethylene Oxide (EO), Gamma and Electron Beam (E-Beam) irradiation. We also provide process capabilities for Food Safety and High Performance Specialty Materials using our Gamma and Electron Beam radiation technologies. With over 1,300 employees and 38 service centers around the world, Sterigenics is able to offer more choices of location as well as the widest range of advanced technological solutions and support services to our customers.
Signatur Biosciences
Signatur Biosciences, founded in 2022, focuses on advancing molecular diagnostics through an innovative PCR testing platform. This technology streamlines the detection and interpretation of RNA biomarkers into a single test, making precision diagnostics more accessible. The company's smart kit is designed to be compatible with existing clinical machines and off-the-shelf reagents, allowing clinicians to seamlessly integrate the testing process into their current workflows. By simplifying the diagnostic process, Signatur Biosciences aims to enhance the efficiency and effectiveness of clinical diagnostics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.